← SynDRA
BICTEGRAVIR
SynDRA canonical compound SYN0039099 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | HIV integrase inhibitor |
|---|
| Indication | human immunodeficiency virus (HIV-1) |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- HIV integrase inhibitor
- pol INHIBITOR
ATC classes
Cross-references
Synonyms
- bictegravir sodium
- GS-9883
- GS-9883-01
- GS 9883
- bictegravirum
- 8GB79LOJ07
- CHEBI:172943
- RefChem:568041
- DTXCID901513504
- Bictegravir [INN]
- Bictegravir (100 mg/mL in DMSO)
- Bictegravir [USAN:INN]
- UNII-8GB79LOJ07
- Bictegravin
- Bictegravir?
- C21H18F3N3O5
- MFCD31536971
- Bictegravir (Standard)
- BICTEGRAVIR [MI]
- Bictegravir (USAN/INN)
- Bictegravir, (+/-)-
- BICTEGRAVIR [USAN]
- RY7J24S9ZL
- BICTEGRAVIR [WHO-DD]
- SCHEMBL15914278
- GTPL11575
- SOLUWJRYJLAZCX-LYOVBCGYSA-N
- BDBM330048
- EX-A3161
- EBC-27122
- GS9883
- HY-17605R
- s5911
- AKOS032954062
- DT-0020
- AC-30658
- DA-51105
- HY-17605
Reported adverse events
- Abnormal dreams
- Angioedema
- Dizziness
- Fanconi syndrome
- Fatigue
- Headache
- Hepatitis B
- Hepatomegaly
- Insomnia
- Nausea
- Stevens-Johnson syndrome
- Suicidal ideation
Look up BICTEGRAVIR in the interactive SynDRA portal →